Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Complete Title: A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Select Advanced Solid Tumors
Trial Phase: I
Investigator: Michael Schweizer

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, pharmacodynamics, and early clinical activity of INCB099280 in participants with select solid tumors

Keywords:
  • Cervical Cancer
  • Esophageal Cancer
  • Mesothelioma
  • Nasopharyngeal Cancer
  • Solid Tumors
  • Carcinoma, Squamous Cell
  • Carcinoma, Merkel Cell
  • Carcinoma, Hepatocellular
  • Lung Carcinoma, Small-Cell
  • Urothelial Cancer
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

Adult
I
Michael Schweizer
RG1121128
NCT04242199
A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Select Advanced Solid Tumors
Cervical Cancer
Esophageal Cancer
Mesothelioma
Nasopharyngeal Cancer
Solid Tumors
Carcinoma, Squamous Cell
Carcinoma, Merkel Cell
Carcinoma, Hepatocellular
Lung Carcinoma, Small-Cell
Urothelial Cancer